Zacks Investment Research
14 Jul 2026, 22:51 UTC · 7w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
Amgen's projected EPS for the upcoming quarter is $5.55, representing a 7.81% decrease compared to the same period last year. — A significant year-over-year decline in earnings per share typically pressures stock prices and suggests weakening profitability.
-0.40Amgen currently trades at a Forward P/E ratio of 16.25, which is a discount compared to the industry average of 20.52. — A valuation discount relative to peers may attract value investors, potentially providing a price floor.
+0.30Amgen is projected to generate revenue of $9.45 billion in the coming quarter, a 2.9% increase over the prior year. — Modest revenue growth provides some fundamental support, though it is overshadowed by the projected earnings drop.
+0.20Continue reading
6 related stories
Top 3 movers · tap to explore
The consensus EPS projection for Amgen has decreased by 0.32% over the last 30 days. — Downward revisions in analyst estimates generally signal a deteriorating short-term outlook.
-0.10Which stocks this story touches
The stock closed lower than the S&P 500 and has a projected EPS drop of 7.81% for the upcoming quarter.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
23h ago
